Holen Sie sich die Stockscreener-App
32.95
6.91%
2.13
Handel nachbörslich:
33.40
0.45
+1.37%
Schlusskurs vom Vortag:
$30.82
Offen:
$31.75
24-Stunden-Volumen:
1.11M
Relative Volume:
0.95
Marktkapitalisierung:
$2.15B
Einnahmen:
$277.49M
Nettoeinkommen (Verlust:
$-192.14M
KGV:
-9.8065
EPS:
-3.36
Netto-Cashflow:
$-95.52M
1W Leistung:
-8.29%
1M Leistung:
-15.19%
6M Leistung:
-27.20%
1J Leistung:
-22.23%
1-Tages-Spanne:
$31.75
$33.46
1-Wochen-Bereich:
$30.72
$35.67
52-Wochen-Spanne:
$30.72
$60.90
Twist Bioscience Corp Stock (TWST) Company Profile
Firmenname
Twist Bioscience Corp
Sektor
Branche
Telefon
800-719-0671
Adresse
681 GATEWAY BLVD., SOUTH SAN FRANCISCO, CA
Vergleichen Sie TWST mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TWST
Twist Bioscience Corp
|
32.95 | 2.15B | 277.49M | -192.14M | -95.52M | -3.36 |
|
TMO
Thermo Fisher Scientific Inc
|
432.59 | 159.40B | 42.90B | 6.52B | 6.72B | 17.05 |
|
DHR
Danaher Corp
|
200.83 | 141.27B | 23.82B | 3.77B | 4.90B | 5.15 |
|
IDXX
Idexx Laboratories Inc
|
509.53 | 38.21B | 3.93B | 894.97M | 837.70M | 10.82 |
|
A
Agilent Technologies Inc
|
115.55 | 30.90B | 6.53B | 1.26B | 1.31B | 4.35 |
|
IQV
Iqvia Holdings Inc
|
156.13 | 26.35B | 15.50B | 1.33B | 2.16B | 7.34 |
Twist Bioscience Corp Stock (TWST) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-13 | Eingeleitet | Wolfe Research | Outperform |
| 2024-06-04 | Eingeleitet | Guggenheim | Buy |
| 2024-01-17 | Hochstufung | Goldman | Neutral → Buy |
| 2023-09-27 | Eingeleitet | Berenberg | Buy |
| 2023-01-05 | Eingeleitet | Scotiabank | Sector Outperform |
| 2023-01-03 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2022-03-02 | Fortgesetzt | Cowen | Outperform |
| 2021-10-15 | Fortgesetzt | Cowen | Outperform |
| 2021-06-29 | Eingeleitet | William Blair | Outperform |
| 2021-06-04 | Eingeleitet | Goldman | Neutral |
| 2021-04-12 | Eingeleitet | Piper Sandler | Overweight |
| 2021-02-05 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2021-01-04 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2020-10-20 | Eingeleitet | SVB Leerink | Mkt Perform |
| 2019-05-31 | Eingeleitet | Evercore ISI | Outperform |
| 2018-11-26 | Eingeleitet | JP Morgan | Neutral |
Alle ansehen
Twist Bioscience Corp Aktie (TWST) Neueste Nachrichten
Billionaire Nicholas J. Pritzker’s 8 Stocks with Huge Upside Potential - Insider Monkey
Twist Bioscience Corporation (TWST): Among Nicholas J. Pritzker’s Stock Picks with Huge Upside Potential - Yahoo Finance
Twist Bioscience and Ginkgo Bioworks update DNA supply deal - Investing.com
Twist Bioscience and Ginkgo Bioworks Revise Collaboration - Business Wire
Twist Bioscience Executives Sell Shares to Cover Tax Obligations - TradingView
Twist Bioscience: Expansion Efforts Continue To Face Challenges (NASDAQ:TWST) - Seeking Alpha
Where Twist Bioscience Stands With Analysts - Benzinga
Goldman Sachs Adjusts Price Target for Twist Bioscience (TWST) | TWST Stock News - GuruFocus
Guggenheim Reiterates Buy Rating on Twist Bioscience (TWST) with $50 Price Target | TWST Stock News - GuruFocus
Twist Bioscience (TWST) Price Target Lowered by Baird | TWST Sto - GuruFocus
JP Morgan Adjusts Price Target for Twist Bioscience (TWST) | TWS - GuruFocus
JP Morgan Adjusts Price Target for Twist Bioscience (TWST) | TWST Stock News - GuruFocus
Twist Bioscience Corporation (NASDAQ:TWST) Q2 2025 Earnings Call Transcript - Insider Monkey
Twist Bioscience (TWST) Price Target Adjusted by Analyst | TWST Stock News - GuruFocus
JPMorgan Adjusts Price Target for Twist Bioscience (TWST) | TWST Stock News - GuruFocus
Twist Bioscience Corp (TWST) Q2 2025 Earnings Call Highlights: R - GuruFocus
Twist Bioscience Corp (TWST) Q2 2025 Earnings Call Highlights: Record Revenue and Strategic ... - Yahoo Finance
Twist Bioscience stock holds $58 target, safe from headwinds By Investing.com - Investing.com Canada
Twist Bioscience: Fiscal Q2 Earnings Snapshot - MySA
Twist Bioscience (TWST) Reports Q2 Revenue and New Business Laun - GuruFocus
Twist Bioscience stock holds $58 target, safe from headwinds - Investing.com Australia
Leerink maintains $40 target on Twist Bioscience stock - Investing.com
Twist Bioscience (TWST) Unveils DNA Storage Spin-Off and Reports Strong Q2 Growth - GuruFocus
Barclays maintains $45 target on Twist Bioscience stock - Investing.com
Twist Bioscience stock target trimmed to $50 by Evercore ISI - Investing.com
Twist Bioscience earnings missed by $0.05, revenue topped estimates - Investing.com Canada
Twist Bioscience (TWST) Q2 Earnings: Revenue Surges but EPS Falls Short - GuruFocus
Twist Bioscience Corp Q2 FY25 Earnings: Revenue Surpasses Estima - GuruFocus
Twist Bioscience (TWST) Spins Off Atlas Data Storage - GuruFocus
Earnings call transcript: Twist Bioscience Q2 2025 revenue rises, stock reacts positively - Investing.com Nigeria
TWIST BIOSCIENCE Earnings Results: $TWST Reports Quarterly Earnings - Nasdaq
Twist Bioscience (TWST) reports Q2 loss, tops revenue estimates - FXStreet
Twist Bioscience Corp reports results for the quarter ended March 31Earnings Summary - TradingView
Twist Bioscience Q2 2025 slides: revenue grows 23%, margins approach 50% target - Investing.com
Twist Bioscience (TWST) Reports Q2 Loss, Tops Revenue Estimates - Yahoo Finance
Twist Bioscience Announces Fiscal 2025 Second Quarter Financial Results - marketscreener.com
Twist Bioscience Spins Out DNA Data Storage As Independent Company - marketscreener.com
Twist Bioscience Corp Q2 FY25 Earnings: Revenue Surpasses Estimates at $92.8M, EPS Misses at -$0.58 - GuruFocus
Twist Bioscience Launches Atlas Data Storage as Independent Company With $155M Backing - marketscreener.com
Twist Bioscience (TWST) Reports Q2 Revenue and New Business Launch | TWST Stock News - GuruFocus
Twist Bioscience (TWST) Spins Off DNA Storage Unit as Atlas Data Storage | TWST Stock News - GuruFocus
Twist Bioscience Fiscal Q2 Loss Narrows, Revenue Rises; 2025 Sales Outlook Maintained - marketscreener.com
Twist Bioscience Spins Out DNA Data Storage as Independent Company - Business Wire
Twist Bioscience (TWST) Projected to Post Earnings on Monday - Defense World
What's Next: Twist Bioscience's Earnings Preview - Nasdaq
What To Expect From Twist Bioscience Corp (TWST) Q2 2025 Earnings - GuruFocus
Deeper Dive: Understanding Twist Bioscience Corp (TWST) Through its Various Ratios - DWinneX
Twist Bioscience: Experiencing Solid Growth But Significantly Overvalued (NASDAQ:TWST) - Seeking Alpha
How did Twist Bioscience Corp (TWST) fare last session? - uspostnews.com
Analyzing Twist Bioscience Corp (TWST) After Recent Trading Activity - knoxdaily.com
Envestnet Asset Management Inc. Acquires 19,340 Shares of Twist Bioscience Co. (NASDAQ:TWST) - Defense World
Finanzdaten der Twist Bioscience Corp-Aktie (TWST)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.60%
2.12%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):